10Feb 2020

CD44 GENE POLYMORPHISM IN EGYPTIAN PATIENTS WITH VITILIGO

  • MSc, (Dermatology & Andrology) Faculty of Medicine Benha University.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Vitiligo is an autoimmune polygenic disorder, characterized by loss of pigmentation due to melanocyte destruction. Multiple genes and environmental triggers are thought to play a role in inducing vitiligo. Etiological hypothesis suggested for etiopathogenesis of vitiligo include gender, immunological, neuro-hormonal and other environmental factors. Genes possibly play a role in all aspects of pathogenesis of vitiligo. Most genes associated with vitiligo are involved in immune regulation and immune targeting of melanocytes. These genes and environmental factors differ across different population. Vitiligo is the most common depigmenting disorder, with a prevalence of approximately (0.5-2%) in the world population. CD44 gene has been linked with the development of several autoimmune disorders. CD44 is encoded by single gene, located on chromosome 11p13. CD44 is a cell surface glycoprotein with various functions, and is involved in a number of biological processes including lymphocyte migration, extravasations, homing, activation, and apoptosis, especially those involving a role in T-cell development. The purpose of the present work was to investigate the association between an inherited genetic polymorphism at CD44 gene and vitiligo in Egyptian patients. The present study included 50 vitiligo patients and 49 apparently healthy age and sex matched subjects as control group. Patients were recruited from the outpatient clinic of Dermatology and Andrology Department Benha university hospitals. All studied individuals were subjected to complete history taking and complete clinical examination. Patients were classified into three types (vitiligo vulgaris, acrofacial and universalis) and disease extent was assessed by body surface area (BSA) score. This study included 2 groups; patients group included 50 patients with vitiligo, 15 males (30%) and 35 females (70%), and control group included 49 healthy, age and sex matched individuals. This sample of individuals was selected randomly from population in Qalyubia Governate. Results of the present study showed a statistically insignificant difference between vitiligo patients and control groups regarding the frequency of CD44 genotypes and alleles.

  1. Alkhateeb A, Fain PR, Thody A et al. (2003): Epidemiology of vitiligo and associated autoimmune diseases in Caucasian and their families.Pigment Cell? Res;16:208-214.
  2. Alikhan A, Felsten LM, Daly M, et al. (2011): Vitiligo a comphensiveoverview Part I. Introduction, epidemiology, quality of life, diagnosis . J Am AcadDermatol; 65: 473-91.
  3. Baaten BJ, Li CR and Bradley LM. (2010): Multifaceted regulation of T-cells by CD44. CommunIntegrBiol;3: 508?512.
  4. Dogra S and Kumar B (2005):.Repigmentation in vitiligouniversalis: Role of melanocyte density, disease duration and melanocytic reservoir. J DermatolOnline ; 11: 30.
  5. EstessP1, DeGrendele HC, Pascual V et al. (1999): Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.
  6. J Clin Invest; 102(6):1173-1182.
  7. Hernandez J, Aung S, Redmond WL et al. (2001): Phenotypic and functional analysis of CD8(+) T-cells undergoing peripheral deletion in response to cross-presentation of selfantigen. J Exp Med ;14:707?717.
  8. Horton MR, Shapiro S, Bao C, et al. (1999): Induction and Regulation of Macrophage Metalloelastase by Hyaluronan Fragments in Mouse Macrophages. J Immunology; 162 (7) 4171-4176
  9. Jahan P, Cheruvu R, Tippisetty S et al. (2013): Association of FOXP3 promoter polymorphism with nondermatomalvitiligo study from India.J Am AcadDermatol.; 69(2): 262-266.
  10. Jin Y, Birlea SA, Fain PR et al. (2012): Genome wide association analyses identify 13 new susceptibility loci for generalized vitiligo.Nat Genet; 44(6): 676?68.
  11. Li F, Tiede B, Massagu? Jet al.(2007): Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research;17 (1): 3?14.
  12. Liu M, Li S, Yang J et al. (2005) : Clinical profiles of vitiligo in China. ClinExpDermatol; 30:327?331.
  13. Karelson M, Silm H, Salum T et al. (2012) : Differeances between familial and sporadic cases of vitiligo.
  14. J EurAcadDermatolVenereol ; 26(7): 915?918.
  15. Misri R, Khopkar U, Shankarkumar U et al. (2009) : Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilialvitiligo.
  16. Indian J DermatolVenereolLeprol; 75:583-7.
  17. .Nunes DH and Esser LM (2011):
  18. Vitiligo epidemiological profile and the association with thyroid disease.An Bras Dermatol; 86: 241-8.
  19. Onay H, Pehlivan M, Alper S et al. (2007) : Might there be a link between mannose binding lectin and vitiligo. Eur J Dermatol ;17, 146?148.
  20. Oxley SM and Sackstein R (1994): Detection of an L-selectin ligand on a hematopoietic progenitor cell line.Blood ; 84 (10): 3299?306.
  21. Rangaswami H, Bulbule A and Kundu GC (2006):? Osteopontin: role in cell signaling and cancer progression.? Trends Cell Biol; 16:79-87.
  22. Sillanp?? S, Anttila MA, Voutilainen K, et al. (2003): CD44 expression indicates favorable prognosis in epithelial ovarian cancer . Clin Cancer Res; 9 (14): 5318?24.
  23. Spritz RA (2011): Recent progress in the genetics: Genome wide studies provide insights into autoimmune pathogenesis.
  24. J Invest Dermatol.; 132:268-273.
  25. Sehgal and Srivastava (2007) : Vitiligo Compendium of clinico-epidemiological features. Indian J DermatolVenereolLeprol ;73:149-56.
  26. Shajil EM, Chatterjee S, Agrawal D et al. (2006): Vitiligopatho mechanisms and genetic polymorphism of susceptible genes.Indian J ExpBiol; 44(7): 526-539.
  27. Tijink B, Buter J, Giaccone G et al. (2006) : Aphase does escalation study with antiCD44v6 bivatuzumabmertansine in patient with incurable squamous cell carcinoma of the head and neck. Clin Cancer Res; 12:6064-6072.

[Omar Yousif Dhannoon (2020); CD44 GENE POLYMORPHISM IN EGYPTIAN PATIENTS WITH VITILIGO Int. J. of Adv. Res. 8 (Feb). 1230-1238] (ISSN 2320-5407). www.journalijar.com

Dr.Omar Yousif Dhannoon
(Dermatology & Andrology) Faculty of Medicine Benha University

DOI:

Article DOI: 10.21474/IJAR01/10572      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10572

Download Full Paper

Download PDF No. of Downloads: 18 | No. of Views: 81